A randomized, double-blind, placebo-controlled, multicenter, parallel-group, detrmination-range dose of MK-0633 performed in adult patients with COPD. MK 633-007

Project: Research/Creation Project

Project Details

Description

N/A
StatusFinished
Effective start/end date1/2/081/1/09